Literature DB >> 2638347

Quantitating the effect of cystic fibrosis on linear growth by mathematical modelling of longitudinal growth curves.

L B Barkhouse1, J Fahey, C T Gillespie, D E Cole.   

Abstract

Cystic fibrosis (CF) is a systemic disorder that may compromise linear growth in childhood, but quantitating this effect requires accurate mathematical models for normal growth. Anthropometric measurements on a cohort of 37 CF patients were analyzed using the growth model of Preece and Baines (1978) which reduces longitudinal height data to 6 quantitative parameters. When parameter means for CF females (n = 19) were compared to the reference population in the Harpenden growth study, the overall difference was significant (p less than 0.05). Examination of the derived biological parameters revealed 12-month and 14-month delays in age at take off and peak height velocity, respectively, indicating that the pubertal growth spurt in female patients is delayed. Mean ages at take off and peak height velocity were delayed 9 months in the CF males (n = 18). These results reaffirm the observation that CF females experience greater morbidity in later childhood and adolescence than males, and illustrate a quantitative approach that should facilitate further examination of CF and the efficacy of different treatment modalities on the disease process in both sexes.

Entities:  

Mesh:

Year:  1989        PMID: 2638347

Source DB:  PubMed          Journal:  Growth Dev Aging        ISSN: 1041-1232


  10 in total

Review 1.  Growth and growth charts in cystic fibrosis.

Authors:  Leena Patel; Moira Dixon; T J David
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

3.  Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening.

Authors:  Zhumin Zhang; Mary J Lindstrom; Philip M Farrell; HuiChuan J Lai
Journal:  Pediatrics       Date:  2016-04-05       Impact factor: 7.124

4.  Perspectives of longitudinal growth in cystic fibrosis from birth to adult age.

Authors:  G Haeusler; H Frisch; T Waldhör; M Götz
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

5.  Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis.

Authors:  Zhumin Zhang; Mary J Lindstrom; HuiChuan J Lai
Journal:  J Pediatr       Date:  2013-03-25       Impact factor: 4.406

Review 6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

7.  Deficits in bone mineral content in children and adolescents with cystic fibrosis are related to height deficits.

Authors:  Andrea Kelly; Joan I Schall; Virginia A Stallings; Babette S Zemel
Journal:  J Clin Densitom       Date:  2008-08-30       Impact factor: 2.617

Review 8.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

9.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

10.  Genetic potential and height velocity during childhood and adolescence do not fully account for shorter stature in cystic fibrosis.

Authors:  Zofia N Zysman-Colman; Marissa J Kilberg; Victor S Harrison; Alessandra Chesi; Struan F A Grant; Jonathan Mitchell; Saba Sheikh; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein; Andrea Kelly
Journal:  Pediatr Res       Date:  2020-05-09       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.